Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens

Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens

Bibliographic Details
Main Authors:	Grimm S, Ackerman M
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Display of the HIV envelope protein at the yeast cell surface for immunogen development.
by: Elizabeth Mathew, et al.
Published: (2018-01-01)

Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
by: Balraj Premanand, et al.
Published: (2018-05-01)

Design and Characterization of HIV-1 ENV Derived Immunogens
by: Purwar, Mansi
Published: (2018)

Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles
by: Melo, Mariane Bandeira, et al.
Published: (2021)

Selected HIV-1 Env trimeric formulations act as potent immunogens in a rabbit vaccination model.
by: Leo Heyndrickx, et al.
Published: (2013-01-01)

Engineering of HIV gp120 by yeast surface display for neutralizing antibody characterization and immunogen design
by: Mata-Fink, Jordi
Published: (2013)

Development of chimeric HIV Env immunogens for mucosal delivery with attenuated canine distemper virus (CDV) vaccine vectors
by: Zhang X, et al.
Published: (2012-09-01)

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
by: Pejawar-Gaddy S, et al.
Published: (2012-09-01)

Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
by: Pejawar Gaddy, Sharmila, et al.
Published: (2013)

Design of Lipid Nanocapsule Delivery Vehicles for Multivalent Display of Recombinant Env Trimers in HIV Vaccination
by: Pejawar-Gaddy, Sharmila, et al.
Published: (2015)

Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM
by: Aleksandar Antanasijevic, et al.
Published: (2021-08-01)

Viral vector delivery of Env trimer immunogens
by: Parks CL, et al.
Published: (2012-09-01)

Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012).
by: Michelle C Crank, et al.
Published: (2016-01-01)

Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine.
by: Katharina Böckl, et al.
Published: (2012-01-01)

P04-24. Frequencies of HIV Env-specific B cells and neutralizing antibodies during DNA-prime/protein-boost immunization with three different Env immunogens*
by: Stamatatos L, et al.
Published: (2009-10-01)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
by: Yoann Aldon, et al.
Published: (2021-09-01)

Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.
by: Sebastian K Grimm, et al.
Published: (2015-01-01)

A novel rabbit monoclonal antibody platform to dissect the diverse repertoire of antibody epitopes for HIV-1 Env immunogen design
by: Chen Y, et al.
Published: (2012-09-01)

Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env
by: Christopher A. Gonelli, et al.
Published: (2021-03-01)

Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display.
by: Daniel O Connor, et al.
Published: (2016-01-01)

Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination
by: Rebecca Heß, et al.
Published: (2019-02-01)

An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.
by: Anke Schultz, et al.
Published: (2012-01-01)

Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
by: Aleksandar Antanasijevic, et al.
Published: (2020-08-01)

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles
by: Philip J. M. Brouwer, et al.
Published: (2021-02-01)

Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein.
by: Mark D Hicar, et al.
Published: (2016-01-01)

Polyethyleneimine as a candidate vaccine adjuvant for Env-based HIV-1 infection
by: Brinckmann, Sarah Anna
Published: (2012)

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
by: Andrew T. McGuire, et al.
Published: (2016-02-01)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
by: Stamatatos L, et al.
Published: (2009-10-01)

Protein Engineering of HIV-1 Env and Human CD4
by: Saha, Piyali
Published: (2018)

Characterisation of the HIV-1 subtype C Env gene and the expression of the Env protein from selected isolates in mammalian cells
by: De Villiers, Tania
Published: (2012)

Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
by: Bartek Nogal, et al.
Published: (2020-03-01)

Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
by: Brandon F. Keele, et al.
Published: (2017-06-01)

Immunogenicity of HIV gag Plasmid combined with Flagella Protein by Intramuscular Vaccination
by: Yi-Chien Hung, et al.
Published: (2009)

Repeated Vaccination of Cows with HIV Env gp140 during Subsequent Pregnancies Elicits and Sustains an Enduring Strong Env-Binding and Neutralising Antibody Response.
by: Behnaz Heydarchi, et al.
Published: (2016-01-01)

Yeast Surface-Displayed H5N1 Avian Influenza Vaccines
by: Han Lei, et al.
Published: (2016-01-01)

Efficient yeast surface-display of novel complex synthetic cellulosomes
by: Hongting Tang, et al.
Published: (2018-08-01)

Malaria vaccine candidates displayed on novel virus-like particles are immunogenic and induce transmission-blocking activity.
by: Jo-Anne Chan, et al.
Published: (2019-01-01)

Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
by: Jyotiranjan Bal, et al.
Published: (2018-02-01)

Founder virus envelope glycoproteins as novel oligomeric HIV-1 vaccine immunogens
by: Killick, Mark Andrew
Published: (2015)

Differences in Allelic Frequency and CDRH3 Region Limit the Engagement of HIV Env Immunogens by Putative VRC01 Neutralizing Antibody Precursors
by: Christina Yacoob, et al.
Published: (2016-11-01)

Cannot write session to /tmp/vufind_sessions/sess_h9pdf7huhd8b4652nkp4ag1ao2